Wound Care in Massachusetts

Bruce Medical Supply is an established home health and medical consumables distributor operating for over 40 years. The company specializes in ostomy, incontinence, and wound care supplies; laryngectomy and tracheostomy management products; and convalescent home health solutions. Product lines include ADDvox-branded stoma accessories (moisture exchange scarves, turtlenecks, humidified filters, shower shields), ostomy care tools and closures from Hollister and other manufacturers, disposal envelopes, no-rinse body wash wipes and baths, inflatable shampoo basins, and professional supplies including vinyl examination gloves, sterile alcohol prep wipes, disposable face masks, and sodium chloride USP. The company also carries thickened food and beverage products (Thick & Easy), humidifiers, aspirators, nebulizers, and specialty dinnerware for patients with swallowing difficulties. Bruce Medical Supply offers same-day shipping, free shipping on orders over $75, and a 60-day 100% satisfaction guarantee. The distribution model targets homecare patients, convalescent facilities, and healthcare professionals requiring consumables and disposable medical supplies.

Organogenesis Inc. is a regenerative medicine company headquartered in Canton, Massachusetts, specializing in advanced wound care, surgical solutions, and sports medicine products. The company develops and manufactures innovative tissue-based regenerative therapies and biologics designed to support clinical healing across multiple therapeutic areas. Their primary focus areas include advanced wound care products for burn and chronic wounds, and surgical/sports medicine applications. Organogenesis operates under FDA oversight and maintains regulatory compliance for their regenerative tissue products. The company supports healthcare providers through a "Circle of Care" program that includes patient and provider resources, reimbursement expertise, and regulatory guidance. In 2025, Organogenesis announced expansion of manufacturing and R&D capabilities with a new state-of-the-art biomanufacturing facility in Smithfield, Rhode Island, designed to support both existing and planned regenerative medicine products. The company employs reimbursement and regulatory specialists to manage compliance and market access for their product portfolio. Organogenesis serves U.S. healthcare providers and institutions, with a commitment to delivering science-based regenerative solutions that empower clinical healing.

Gel4Med is a commercial-stage biomaterials company founded from Harvard Innovation Labs, developing novel biosynthetic wound care and surgical reconstruction products using proprietary Smart Materials Platform (SMP™) technology. The company specializes in self-assembling peptide-based matrices engineered to address complex wound management and high-risk surgical closure. Their lead products, G4Derm™ Plus and Suprello™ Wound Matrix, both received FDA 510(k) clearance in October 2023. G4Derm™ Plus is a flowable biomimetic matrix for complex wound management, while Suprello™ is a peptide-based wound matrix for secure closure and healing in high-risk surgical cases. The company's platform approach enables development of advanced biomaterials for wound care and surgical reconstruction applications. Gel4Med has received significant funding from the National Institutes of Health Commercial Readiness Pilot program and U.S. Department of Defense, and is collaborating with the University of Miami on spinal cord injury treatments. The company maintains R&D facilities at UMass Lowell and headquarters in Brighton, Massachusetts. Products are indicated for wound care, surgical reconstruction, and tissue management applications.